Bialkylating agents form DNA-protein crosslinks (DPCs) as a side reaction. Bialkylating agents belong to a class of drugs used to treat cancer that function by forming DNA-DNA crosslinks and interfering with DNA function. To a lesser extent, they also form DNA-protein crosslinks (DPCs). DPCs are know to be harmful to the cell, but they have not been well-studied.
The aim of our research was to study these DPCs and better understand their mechanism of action. A better understanding of the function of DPCs could one day contribute to the development of novel and more efficacious drugs used to treat cancer.
Additional contributors: Thuy Nguyen-Tran; Colin R. Campbell (faculty mentor)
Anwah, Ifeanyirochukwu G..
Creation of a DNA Substrate for the Investigation of DNA-Protein Crosslinks.
Retrieved from the University of Minnesota Digital Conservancy,
Content distributed via the University of Minnesota's Digital Conservancy may be subject to additional license and use restrictions applied by the depositor.